CD155 as an emerging target in tumor immunotherapy

UALCAN: An update to the integrated cancer data analysis platform

Darshan S. Chandrashekar, Santhosh Kumar Karthikeyan, Praveen Kumar Korla et al. · Neoplasia · 2022 · 2.5K citations · Full text

Life Sciences, Bioinformatics, Oncology +17

The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function

Robert J. Johnston, Laëtitia Comps‐Agrar, Jason A. Hackney et al. · Cancer Cell · 2014 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +12

Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

Thomas Powles, Jonathan E. Rosenberg, Guru Sonpavde et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +14

Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity

Qing Zhang, Jiacheng Bi, Xiaodong Zheng et al. · Nature Immunology · 2018 · 1.1K citations

Life Sciences, Immunology, Oncology +16

Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses

Nicole Joller, Ester Lozano, Patrick R. Burkett et al. · Immunity · 2014 · 934 citations · Full text

Life Sciences, Cell Biology, Immunology +14